BioCentury | Aug 1, 2020
Tools & Techniques

Lurie winner and incoming Genentech R&D chief Aviv Regev looks to gene programs to untangle complex diseases

...and drug-resistant melanoma. In 2016, she and Sarah Teichmann, head of cellular genetics at the Wellcome Trust Sanger Institute...
BioCentury | Apr 1, 2019
Finance

Backing Cambridge's AI boom

...a company employing this approach - Congenica Ltd. (Cambridge, U.K.). Based on research from the Wellcome Trust Sanger Institute...
BioCentury | Apr 20, 2018
Company News

Broad launches tool to identify vulnerabilities of cancer cells

...lines. DepMap pools data from Broad’s Project Achilles; the Broad-Novartis Cancer Cell Line Encyclopedia; the Wellcome Trust Sanger Institute's...
BioCentury | Apr 16, 2018
Tools & Techniques

Broad launches tool to identify vulnerabilities of cancer cells

...lines. DepMap pools data from Broad’s Project Achilles; the Broad-Novartis Cancer Cell Line Encyclopedia; the Wellcome Trust Sanger Institute's...
BioCentury | Mar 28, 2018
Distillery Techniques

Biomarkers

...E. et al. Nat. Genet. ; published online Mar. 19, 2018 doi:10.1038/s41588-018-0079-y CONTACT: Eleftheria Zeggini, Wellcome Trust Sanger Institute...
BioCentury | Mar 1, 2018
Targets & Mechanisms

Checking out the microbiome

...Location Founded Raised ($M) Partners Partnership scope Therapy type Microbiotica Ltd. Cambridge, U.K. 2016 $10 Wellcome Trust Sanger Institute...
BioCentury | Feb 15, 2018
Emerging Company Profile

Cultural shift

...was spun out of the labs of co-founders Trevor Lawley and Gordon Dougan at the Wellcome Trust Sanger Institute...
...Clinical status: Preclinical Founded: 2016 by Trevor Lawley, Gordon Dougan and Mike Romanos University collaborators: Wellcome Trust Sanger Institute...
...Institutes of Health (NIH), Bethesda, Md. Nestlé S.A., Vevey, Switzerland Seres Therapeutics Inc., Cambridge, Mass. Wellcome Trust Sanger Institute...
BioCentury | Jan 4, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: December 2017

...Bone cancer Lysosomal trafficking regulator (LYST) Truncating mutations in LYST could help diagnose sporadic chordoma. Wellcome Trust Sanger Institute...
BioCentury | Dec 13, 2017
Distillery Techniques

Biomarkers

...et al. Nat. Commun. ; published online Oct. 12, 2017 doi:10.1038/s41467-017-01026-0 CONTACT: Peter J. Campbell, Wellcome Trust Sanger Institute...
BioCentury | Dec 5, 2017
Distillery Therapeutics

Cancer

...2017 doi:10.1038/nature24678 CONTACT: Tony Kouzarides, University of Cambridge, Cambridge, U.K. email: t.kouzarides@gurdon.cam.ac.uk CONTACT: George Vassiliou, Wellcome Trust Sanger Institute...
Items per page:
1 - 10 of 93
BioCentury | Aug 1, 2020
Tools & Techniques

Lurie winner and incoming Genentech R&D chief Aviv Regev looks to gene programs to untangle complex diseases

...and drug-resistant melanoma. In 2016, she and Sarah Teichmann, head of cellular genetics at the Wellcome Trust Sanger Institute...
BioCentury | Apr 1, 2019
Finance

Backing Cambridge's AI boom

...a company employing this approach - Congenica Ltd. (Cambridge, U.K.). Based on research from the Wellcome Trust Sanger Institute...
BioCentury | Apr 20, 2018
Company News

Broad launches tool to identify vulnerabilities of cancer cells

...lines. DepMap pools data from Broad’s Project Achilles; the Broad-Novartis Cancer Cell Line Encyclopedia; the Wellcome Trust Sanger Institute's...
BioCentury | Apr 16, 2018
Tools & Techniques

Broad launches tool to identify vulnerabilities of cancer cells

...lines. DepMap pools data from Broad’s Project Achilles; the Broad-Novartis Cancer Cell Line Encyclopedia; the Wellcome Trust Sanger Institute's...
BioCentury | Mar 28, 2018
Distillery Techniques

Biomarkers

...E. et al. Nat. Genet. ; published online Mar. 19, 2018 doi:10.1038/s41588-018-0079-y CONTACT: Eleftheria Zeggini, Wellcome Trust Sanger Institute...
BioCentury | Mar 1, 2018
Targets & Mechanisms

Checking out the microbiome

...Location Founded Raised ($M) Partners Partnership scope Therapy type Microbiotica Ltd. Cambridge, U.K. 2016 $10 Wellcome Trust Sanger Institute...
BioCentury | Feb 15, 2018
Emerging Company Profile

Cultural shift

...was spun out of the labs of co-founders Trevor Lawley and Gordon Dougan at the Wellcome Trust Sanger Institute...
...Clinical status: Preclinical Founded: 2016 by Trevor Lawley, Gordon Dougan and Mike Romanos University collaborators: Wellcome Trust Sanger Institute...
...Institutes of Health (NIH), Bethesda, Md. Nestlé S.A., Vevey, Switzerland Seres Therapeutics Inc., Cambridge, Mass. Wellcome Trust Sanger Institute...
BioCentury | Jan 4, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: December 2017

...Bone cancer Lysosomal trafficking regulator (LYST) Truncating mutations in LYST could help diagnose sporadic chordoma. Wellcome Trust Sanger Institute...
BioCentury | Dec 13, 2017
Distillery Techniques

Biomarkers

...et al. Nat. Commun. ; published online Oct. 12, 2017 doi:10.1038/s41467-017-01026-0 CONTACT: Peter J. Campbell, Wellcome Trust Sanger Institute...
BioCentury | Dec 5, 2017
Distillery Therapeutics

Cancer

...2017 doi:10.1038/nature24678 CONTACT: Tony Kouzarides, University of Cambridge, Cambridge, U.K. email: t.kouzarides@gurdon.cam.ac.uk CONTACT: George Vassiliou, Wellcome Trust Sanger Institute...
Items per page:
1 - 10 of 93